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Abstract
 
We recently purified lipoteichoic acid (LTA) from 
 
Staphylococcus aureus
 
 to more than 99% pu-
rity by a novel preparation method and deduced its structure with the first nuclear magnetic
resonance (NMR) of a complete LTA. In contrast to Gram-negative lipopolysaccharides, this
LTA requires the toll-like receptor (TLR)-2 and not TLR-4 for cytokine induction in mono-
cytes and macrophages. To elucidate the structure–function relationships for LTA from 
 
S. au-
reus
 
, the lipid anchor was prepared by either acidic hydrolysis of native LTA or chemical
synthesis (gentiobiosyl-
 
sn
 
-dimyristoylglycerol). Next, a complete LTA molecule with six glyc-
erophosphate units carrying four alanine plus one 
 
N
 
-acetyl-glucosamine substituent was syn-
thesized, which displayed the same potency to activate monocytes as native LTA. However,
100–1,000 times higher concentrations of the lipid anchor were required for cytokine induc-
 
tion. It is worthy to note that replacing 
 
d
 
-alanine with 
 
l
 
-alanine blunted the effect indicating
stereoselective recognition. The structure identification of this synthesized and biologically ac-
tive LTA was proven by NMR and matrix-assisted laser desorption-ionization mass spectrom-
etry. We concluded that the lipid anchor, with its fatty acids, represents an integral part of the
immunostimulatory activity of LTA, but requires additional structural components on the
polyglycerophosphate backbone.
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Introduction
 
The inflammatory responses to Gram-negative and Gram-
positive bacteria can hardly be distinguished. However, al-
though most of the immune stimulation caused by Gram-
negative bacteria could be attributed to LPS as a general
principle, no consensus as to its Gram-positive counterpart
was reached during the last decades. LPS has been available
in a pure, biologically active form since 1952 (1) and its ac-
tive principle, the lipid anchor lipid A, was finally proven
by chemical synthesis in 1985 (2). More than 45,000 Med-
line-listed scientific papers since 1966 describe biological
activities of LPS.
Lipoteichoic acid (LTA) is found in most Gram-positive
bacteria. Like LPS, it is an amphiphilic, negatively charged
glycolipid. For three decades there has been intense dis-
cussion about whether or not LTA represents a counterpart
to LPS. Many studies were performed with commercial
preparations of poor quality and the significant activities re-
ported could, in many instances, be traced back to LPS
contaminations (3–6). When adequately purified, phenol-
extracted LTA from both 
 
Staphylococcus aureus
 
 (7, 8) and
 
Enterococcus hirae
 
 (9) turned out to be essentially inactive in
inducing cytokine release as a measure of immunostimula-
tory activity. Furthermore, a synthetic LTA derivative was
found to have no stimulatory activity (10–12). These ob-
servations have put into doubt the general role of LTA as
an immunostimulator. We have recently shown that many
of these concerns resulted from the inappropriate prepara-
tion methods used for LTA (13). After the phenol extrac-
tion, which is also used for LPS, we obtained partially de-
graded LTA. A novel, more gentle preparation scheme led
to essentially homogenous, biologically active LTA. By
means of structural analysis, we could attribute a crucial
role to preserved 
 
d
 
-alanine substituents of the polyglycero-
 
phosphate backbone of LTA (13). As a ﬁnal proof of the
biological activity of LTA, and to allow structure–func-
tion analysis, the chemical synthesis of a biologically ac-
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tive LTA based on the structure of the one from 
 
S. aureus
 
was performed.
 
Materials and Methods
 
Synthesis Strategy for LTA.
 
To confirm the structural assign-
ment and the biological effect, compound 1, having six glycerol
phosphate residues, was planned as the synthetic target. Thus, the
proportion of the substituents 
 
d
 
-Ala (66%), 
 
d
 
-GlcNAc (17%),
and hydrogen (17%) at the 2-O position of the glycerol moiety
corresponds approximately to the distributions found in the natu-
ral product, i.e., 
 
d
 
-Ala (70%), 
 
d
 
-GlcNAc (15%), and hydrogen
(17%), respectively (13). Compound 1 was assembled with the
five building blocks shown in Fig. 1 based on a carefully selected
protective group pattern. The phosphorous esters were obtained
based on the phosphitamide methodology. The hydrolytically
highly labile 
 
d
 
-Ala residues were attached in the second to last
step, which was immediately followed by deprotection (hydro-
genolytic removal of all 21 benzyl groups) and purification by hy-
drophobic interaction chromatography on octyl Sepharose (13),
thus providing compound 1 in good overall yield. The structure
was confirmed by nuclear magnetic resonance (NMR) and mass
spectrometry (MS) data (Fig. 2).
 
LTA Structure Analysis.
 
NMR experiments were performed
at 600.13 MHz (
 
1
 
H) and 300 K. The NMR spectra were related
to 3-(trimethylsilyl) 3,3,2,2-tetradeuteropropionic acid Na salt
(d
 
4
 
-TSPA). Homonuclear assignments were taken from double-
quantum filtered correlation, total correlation, rotating frame
Overhauser enhancement, and nuclear Overhauser effect spectra.
 
13
 
C assignments were based on heteronuclear multiple-quantum
correlation. Mass spectra were performed by gas chromatogra-
phy-mass spectrometry (GC-MS) and matrix-assisted laser de-
sorption-ionization time-of-flight (MALDI-TOF) MS.
 
Deacylation of Native LTA.
 
Hydrolysis of LTA from 
 
S. aureus
 
(13) was performed at 37
 
 
 
C for 2 h with 0.1 M NaOH. Fatty ac-
ids of LTA were determined by GC-MS (Hewlett-Packard) as
the respective methyl esters after methanolysis using 2 M HCl in
methanol for 7 h at 85
 
 
 
C. The water phase was neutralized with
NaHCO
 
3
 
 and freed of salts by dialysis in Spectrapor tubing with a
molecular mass cut-off of 1,000 daltons.
Figure 1. Scheme of the synthesis strat-
egy for LTA analogue 1 from S. aureus. 
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Native LTA Anchor Preparation.
 
After hydrolyzing 220 mg
LTA from 
 
S. aureus
 
 (13) with 5 ml hydrofluoric acid (48%) at
2
 
 
 
C for 42 h, 150 ml distilled water and 35 ml saturated
NaHCO
 
3
 
 were added. The lyophilisate was resuspended in 70 ml
H
 
2
 
O/CH
 
2
 
Cl
 
2
 
/MeOH (3:3:1) and centrifuged at 3,200 rpm for 7
min. The pellet was washed with CH
 
2
 
Cl
 
2
 
 and the water layer
with CH
 
2
 
Cl
 
2
 
/MeOH (3:1). The collected organic phases were
evaporated under vacuum at 40
 
 
 
C to a volume of 
 
 
 
15 ml and
lyophilized. An aliquot of the lyophilisate (10 mg) was resolved in
200 
 
 
 
l methanol and subjected to a high performance thin layer
chromatography plate silica gel 60 without fluorescent indicator
using the solvent system CHCl
 
3
 
/MeOH/H
 
2
 
O (65:25:4). The R
 
f
 
of the intact glycolipid was 0.68 (0.42 for anchor with one fatty
acid). The substance line was scratched off and filtered over a
glass filter (pore size 4) under vacuum after suspending with thin
layer chromatography solvent. Finally, the solution was evapo-
rated and lyophilized.
 
Murine Peritoneal Cell Preparation.
 
Male C3H/HeN and
C3H/HeJ mice were purchased from Charles River Laboratories.
The animals received humane care in accordance with the Na-
tional Institutes of Health guidelines and the legal requirements in
Germany. Mice were put to sleep by terminal pentobarbital anes-
thesia (Narcoren™; Merial) and 10 ml of ice-cold PBS (GIBCO
BRL) were injected into the peritoneal cavity. Animals were
shaken gently and the lavage liquid was transferred to siliconized
glass tubes (Vacutainer
 
®
 
; Becton Dickinson). After centrifugation,
cells were resuspended in RPMI 1640 medium (BioWhittaker)
containing 10% FCS (Boehringer) and 100 IU/ml penicillin/
streptomycin (Biochrom), and transferred to 96-well cell culture
plates (10
 
5 
 
cells/well). For the determination of cytokine induc-
tion by LPS, native LTA, or synthetic glycolipids, cells were
stimulated immediately with pyrogen-free saline as solvent
(Braun) at 37
 
 
 
C, 5% CO
 
2
 
 in a humidified atmosphere overnight.
 
Cytokine Induction Assay.
 
Cytokine release of human whole
blood was determined as previously described (15) by incubating
800 
 
 
 
l isotonic sodium chloride solution, 200 
 
 
 
l human heparin-
ized whole blood, and 10 
 
 
 
l stimuli. TNF-
 
  
 
was measured by
sandwich ELISA (Endogen).
 
Results and Discussion
 
For LPS, the key role of fatty acids in binding to cellular
receptors and the activation of monocyte/macrophages is
Figure 2. Identification of synthetic LTA by MALDI-TOF MS and
1H-NMR. (A) Part of negative ion MALDI-TOF mass spectrum of syn-
thetic LTA (calculated molecular weight: 2,248.9). In this mode, different
ionization of the single-charged, deprotonated LTA molecule (M H)   
2,248.5, i.e., ([M K]   2H)    2,288.3 and prompt fragmentation of a
d-alanine group (Ala) ([M Ala] H)    2,177.6 caused peak diversity.
(B) The target structure (upper) and the confirmation by 1H-NMR spec-
trum (lower) are shown. The different signals were assigned to structural
components by color coding. 
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well established (14). When LTA from 
 
S. aureus
 
 was deac-
ylated by alkaline hydrolysis, the material failed to induce
any cytokine release in human whole blood. It is worthy to
note that the deacylated molecule was not an antagonist of
native LTA (2,330 
 
  
 
700 pg/ml TNF-
 
  
 
inducible by 1
 
 
 
g/ml native LTA alone vs. 2,380 
 
  
 
430 pg/ml TNF-
 
 
 
inducible with the addition of 10 
 
 
 
g deacylated LTA; 
 
n 
 
 
 
4, NS), which indicates that it had lost its ability to com-
pete for the cellular binding site.
This finding indicated that the lipid anchor of LTA rep-
resents a key component of its biological activity. There-
fore, the lipid anchor was prepared by hydrofluoric acid
hydrolysis and purified by thin layer chromatography. The
resulting material did stimulate cytokine release in human
whole blood but microgram/milliliter quantities of the
LTA glycolipid were required (Fig. 3 A), whereas 600-fold
less native, complete LTA sufficed for cytokine induction.
Next, the lipid anchor was synthesized. GC-MS analysis of
the native anchor showed a considerable heterogeneity of
fatty acids in the anchor (13) as 
 
 
 
50% of the fatty acids
were methylated. The most frequent fatty acids found were
tetradecanoic acids (
 
 
 
36%), which were chosen for the
lipid anchor synthesis in the nonbranched form. The syn-
thetic molecule displayed activities similar to the natural
isolate (Fig. 3 A). The relative role of different fatty acids
will require further studies. Interestingly, when structurally
very similar compounds were tested, i.e., lactosyl disaccha-
rides that were ether-linked to fatty acids, we found a simi-
lar induction of cytokine release to the lipid anchor (un-
published data). Furthermore, when the racemic mixture of
both stereoisomers of the LTA anchor was compared with
the pure isomer, no major difference in cytokine induction
was observed (Fig. 3 A). In conclusion, the pattern recog-
nition of the lipid anchor is relatively loose, allowing a high
degree of variability of the anchor structure.
The fact that the lipid anchor alone was a factor of 100–
1,000 less potent in inducing cytokine release than native
LTA (Fig. 3 A), prompted the synthesis of a complete LTA
molecule. The synthesis strategy is depicted in Fig. 1. The
assembly of the five building blocks resulted in milligram
quantities of LTA, which was purified by hydrophobic in-
teraction chromatography. The identity of the molecule
was shown by NMR and MS (Fig. 2). The material was
negative in the Limulus test for Gram-negative endotoxin
(i.e., 
 
 
 
10 pg LPS/mg LTA; Endosafe Limulus amebocyte
lysate [LAL] Endochrome; Charles River Laboratories), ex-
cluding an LPS contamination and demonstrating that the
LAL test does not detect this Gram-positive stimulus. The
combination of analytical methods excludes any contami-
nation by more than 1% and the LAL test largely excludes
LPS contamination. The latter notion is supported by the
finding that macrophages from LPS-nonresponsive C
 
3
 
H/
HeJ mice responded similarly to those of LPS-responsive
C
 
3
 
H/HeN mice to both the synthetic lipid anchor and na-
tive LTA (Fig. 4).
The resulting compound was as potent in inducing cy-
tokine formation in human whole blood as the native mol-
ecule (Fig. 3 B). We concluded that the structure of LTA
from 
 
S. aureus
 
 suggested (13), and indeed represents, an im-
munostimulatory molecule. Although the natural com-
pounds termed LTA exist as a rather heterogeneous class of
apparently related molecules, the synthetic compounds ap-
pear to reflect key structural requirements for immune acti-
vation. We confirmed the key role of 
 
d
 
-Ala substituents by
synthesizing the 
 
l
 
-Ala derivative, which made the com-
pound less active by a factor of 100 (Fig. 3 B).
The biological activity of native LTA has been charac-
Figure 3. TNF-  induction by LTA anchor derivatives and synthetic
LTA. (A) The fission products of native LTA from S. aureus, intact an-
chor ( ), partially deacylated anchor ( ), and the synthetic compounds
( , pure diastereomer and  , diastereomeric mixture) were used at the
concentrations indicated to induce TNF-  release in human whole blood
in comparison to native LTA from S. aureus ( ). As a comparison, 10 ng/
ml LPS (Salmonella abortus equi) induced 7,620   3,670 pg/ml TNF- .
Data are given as means   SEM of whole blood incubations of three do-
nors. (B) Human whole blood was incubated in the presence of synthetic
LTA carrying d-alanine ( ) or l-alanine ( ) substituents, or native LTA
( ) at the concentrations indicated. 
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terized recently in several studies (13, 15–19). The fact that
the synthetic LTA behaved very similarly with regard to
potency and pattern of cytokine induction as well as toll-
like receptor use in vitro and in vivo (15, 16), suggests that
it mirrors a major component of the biological isolate
which, however, does not necessarily translate to all activi-
ties of the biological isolates.
Taken together, these studies show that LTA represents
a Gram-positive endotoxin, i.e., a nonsecreted toxin of
bacteria as originally defined. We suggest to broaden the
use of the term endotoxin in this sense, to cover Gram-
negative lipopolysaccharides, Gram-positive LTAs, and
further immunostimulatory structures of the bacterial cell
wall yet to be identified. Furthermore, we suggest to term
the lipid anchor of LTA as “lipid B” in analogy to the
name “lipid A” carried by the LPS anchor. Additional
studies will be required to distinguish the different activities
of LPS and LTA and define the effects of heterogeneities of
the LTA molecule.
 
The authors are indebted to Professor Werner Fischer, who pio-
neered LTA research and introduced us to the field. The valuable
help of Leonardo Cobianchi, Susanne Deininger, Isabel Diterich,
Anke Friemel, Jürgen Kley, Ina Seuffert, and Stephanie Traub is
gratefully appreciated. We thank Sonja von Aulock for help with
the manuscript.
This work was supported by the Deutsche Forschungsgemein-
schaft and the Fonds der Chemischen Industrie.
 
Submitted: 26 February 2002
Revised: 22 April 2002
Accepted: 7 May 2002
 
References
1. Westphal, O., O. Lüderitz, and F. Bister. 1952. Über die Ex-
traktion von Bakterien mit Phenol/Wasser. Z. Naturforsch.
7:148–155.
2. Galanos, C., O. Luederitz, E.T. Rietschel, O. Westphal, H.
Brade, L. Brade, M. Freudenberg, U. Schade, M. Imoto, and
H. Yoshimura. 1985. Synthetic and natural Escherichia coli free
lipid A express identical endotoxic activities. Eur. J. Biochem.
148:1–5.
3. Gao, J.J., Q. Xue, E.G. Zuvanich, K.R. Haghi, and D.C.
Morrison. 2001. Commercial preparations of lipoteichoic
acid contain endotoxin that contributes to activation of
mouse macrophages in vitro. Infect. Immun. 69:751–757.
4. Kawamura, N., N. Imanishi, H. Koike, H. Nakahara, L.
Phillips, and S. Morooka. 1995. Lipoteichoic acid-induced
neutrophil adhesion via E-selectin to human umbilical vein
endothelial cells (HUVECs). Biochem. Biophys. Res. Commun.
217:1208–1215.
5. Sugiyama, A., R. Arakaki, T. Ohnishi, N. Arakaki, Y.
Daikuhara, and H. Takada. 1996. Lipoteichoic acid and in-
terleukin 1 stimulate synergistically production of hepatocyte
growth factor (scatter factor) in human gingival fibroblasts in
culture. Infect. Immun. 64:1426–1431.
6. Morath, S., A. Geyer, I. Spreitzer, C. Hermann, and T. Har-
tung. 2002. Structural decomposition and heterogeneity of
commercial lipoteichoic acid preparations. Infect. Immun. 70:
938–944.
7. Keller, R., W. Fischer, R. Keist, and S. Bassetti. 1992. Mac-
rophage response to bacteria: induction of marked secretory
and cellular activities by lipoteichoic acids. Infect. Immun. 60:
3664–3672.
8. Kusunoki, T., E. Hailman, T.S. Juan, H.S. Lichenstein, and
S.D. Wright. 1995. Molecules from Staphylococcus aureus that
bind CD14 and stimulate innate immune responses. J. Exp.
Med. 182:1673–1682.
Figure 4. Toll-like receptor dependence
of TNF-  induction by synthetic LTA an-
chor. TNF-  induction in murine perito-
neal cells (105 in 220  l) by stimulation with
100 ng/ml LPS, 10  g/ml native LTA, or
28  g/ml synthetic glycolipids. LPS-nonre-
sponsive C3H/HeJ (gray bars) are shown in
comparison to C3H/HeN cells (black bars).
n.d., not detectable. Data are given as
means   SEM of a group of four mice.1640 Cytokine Induction by a Synthetic Lipoteichoic Acid and Derivatives
9. Suda, Y., H. Tochio, K. Kawano, H. Takada, T. Yoshida, S.
Kotani, and S. Kusumoto. 1995. Cytokine-inducing gly-
colipids in the lipoteichoic acid fraction from Enterococcus hirae
ATCC 9790. FEMS Immunol. Med. Microbiol. 12:97–112.
10. Fukase, K., T. Matsumoto, N. Ito, T. Yoshimura, S. Kotani,
and S. Kusumoto. 1992. Synthetic study on lipoteichoic acid
of gram positive bacteria. I. Synthesis of proposed fundamen-
tal structure of Streptococcus pyogenes lipoteichoic acid. Bull.
Chem. Soc. Jpn. 65:2643–2654.
11.  Fukase, K., T. Yoshimura, S. Kotani, and S. Kusumoto.
1994. Synthetic study on lipoteichoic acid of gram positive
bacteria. II. Synthesis of proposed fundamental structure of
Enterococcus hirae lipoteichoic acid. Bull. Chem. Soc. Jpn. 67:
473–482.
12. Oltvoort, J.J., C.A.A. van Boeckel, J.H. de Koning, and J.H.
van Boom. 1982. A simple approach to the synthesis of a
membrane teichoic acid fragment of Staphylococcus aureus.
Recl. Trav. Chim. Pays-Bas. 101:87–91.
13. Morath, S., A. Geyer, and T. Hartung. 2001. Structure–func-
tion relationship of cytokine induction by lipoteichoic acid
from Staphylococcus aureus. J. Exp. Med. 193:393–397.
14. Buck, R.A., J. Cai, P.D. Eleazer, R.H. Staat, and H.E. Hurst.
2001. Detoxification of endotoxin by endodontic irrigants
and calcium hydroxide. J. Endod. 27:325–327.
15. Lehner, M.D., S. Morath, K.S. Michelsen, R.R. Schumann,
and T. Hartung. 2001. Induction of cross-tolerance by li-
popolysaccharide and highly purified lipoteichoic acid via
different Toll-like receptors independent of paracrine media-
tors. J. Immunol. 166:5161–5167.
16. Hermann, C., I. Spreitzer, N.W. Schroder, S. Morath, M.D.
Lehner, W. Fischer, C. Schutt, R.R. Schumann, and T.
Hartung. 2002. Cytokine induction by purified lipoteichoic
acids from various bacterial species—role of LBP, sCD14,
CD14 and failure to induce IL-12 and subsequent IFN-  re-
lease. Eur. J. Immunol. 32:541–551.
17. Opitz, B., N.W. Schroder, I. Spreitzer, K.S. Michelsen, C.J.
Kirschning, W. Hallatschek, U. Zahringer, T. Hartung, U.B.
Gobel, and R.R. Schumann. 2001. Toll-like receptor-2
mediates Treponema glycolipid and lipoteichoic acid-induced
NF-kB translocation. J. Biol. Chem. 276:22041–22047.
18. Michelsen, K.S., A. Aicher, M. Mohaupt, T. Hartung, S.
Dimmeler, C.J. Kirschning, and R.R. Schumann. 2001. The
role of toll-like receptors (TLRs) in bacteria-induced matura-
tion of murine dendritic cells (DCs). Peptidoglycan and li-
poteichoic acid are inducers of DC maturation and require
TLR2. J. Biol. Chem. 276:25680–25686.
19. van de Wetering, J.K., M. van Eijk, L.M. van Golde, T. Har-
tung, J.A. van Strijp, and J.J. Batenburg. 2001. Characteristics
of surfactant protein A and D binding to lipoteichoic acid and
peptidoglycan, 2 major cell wall components of gram-posi-
tive bacteria. J. Infect. Dis. 184:1143–1151.